Ippen Media
VC Fund
Munich, Germany
Ippen Media is a multi-layered media company with a clear vision: growth for journalism with a promising future.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Ippen Media invests in
Stages Ippen Media invests in
Countries Ippen Media invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $7.8M–$11M
- Venture - Series Unknown
- $10M–$47M
Investment Focus
Industry
- Retail 1 (17%)
- Consumer 1 (17%)
- Internet 1 (17%)
- Health Care 1 (17%)
- Manufacturing 1 (17%)
Stage
- Seed 2 (33%)
- Venture - Series Unknown 2 (33%)
- Series A 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Benjamin Marx
CEO
|
CEO | Total investments: 0 | Find email | |
Jan Ippen
Founder and Managing Director
|
Founder and Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Lykon
|
Empower people to live a healthy life. This is not only the vision of our founder Tobias Teuber, but of the entire team. We are a digital health company that was founded in 2018 and will change the healthcare system for the longterm. Our vision is to empower people to take their health into their own hands. We currently offer a wide range of DNAand blood tests. A few drops of blood or saliva are enough for us to provide customers with tailored nutrition and action recommendations to help them achieve their health goals. With our product, we are active in innovative and exciting fields, such as personalized nutrition and personalized medicineHow does it work?You order these tests online, perform them easily at home and send them back to us by post. After our certified partner laboratories have successfully analyzed the blood and DNA samples, you will receive the test results in your private Lykon profile presented in a clear and easy-to-understand way, and at the same time, you will receive recommendations on how to improve your blood values if necessary.Lykon does not replace medical advice, however, we enable you to control your health - without long waiting hours at the doctor's office. | $11M / Seed / Sep 07, 2022 | |
|
Lykon
|
Empower people to live a healthy life. This is not only the vision of our founder Tobias Teuber, but of the entire team. We are a digital health company that was founded in 2018 and will change the healthcare system for the longterm. Our vision is to empower people to take their health into their own hands. We currently offer a wide range of DNAand blood tests. A few drops of blood or saliva are enough for us to provide customers with tailored nutrition and action recommendations to help them achieve their health goals. With our product, we are active in innovative and exciting fields, such as personalized nutrition and personalized medicineHow does it work?You order these tests online, perform them easily at home and send them back to us by post. After our certified partner laboratories have successfully analyzed the blood and DNA samples, you will receive the test results in your private Lykon profile presented in a clear and easy-to-understand way, and at the same time, you will receive recommendations on how to improve your blood values if necessary.Lykon does not replace medical advice, however, we enable you to control your health - without long waiting hours at the doctor's office. | $10M / Venture - Series Unknown / Sep 07, 2022 | |
air up
|
air up is a provider of a drinking bottle system that provides scent-flavored water. The innovation uses retronasal olfaction—where the brain perceives scent through the mouth as taste—to allow the user to enjoy flavored water without added sugars or artificial ingredients. | $46.7M / Venture - Series Unknown / Sep 28, 2021 | |
|
Lykon
|
Empower people to live a healthy life. This is not only the vision of our founder Tobias Teuber, but of the entire team. We are a digital health company that was founded in 2018 and will change the healthcare system for the longterm. Our vision is to empower people to take their health into their own hands. We currently offer a wide range of DNAand blood tests. A few drops of blood or saliva are enough for us to provide customers with tailored nutrition and action recommendations to help them achieve their health goals. With our product, we are active in innovative and exciting fields, such as personalized nutrition and personalized medicineHow does it work?You order these tests online, perform them easily at home and send them back to us by post. After our certified partner laboratories have successfully analyzed the blood and DNA samples, you will receive the test results in your private Lykon profile presented in a clear and easy-to-understand way, and at the same time, you will receive recommendations on how to improve your blood values if necessary.Lykon does not replace medical advice, however, we enable you to control your health - without long waiting hours at the doctor's office. | $7.8M / Seed / Jun 14, 2021 | |
|
air up
|
air up is a provider of a drinking bottle system that provides scent-flavored water. The innovation uses retronasal olfaction—where the brain perceives scent through the mouth as taste—to allow the user to enjoy flavored water without added sugars or artificial ingredients. | $21.2M / Series A / Oct 07, 2020 | |
|
air up
|
air up is a provider of a drinking bottle system that provides scent-flavored water. The innovation uses retronasal olfaction—where the brain perceives scent through the mouth as taste—to allow the user to enjoy flavored water without added sugars or artificial ingredients. | Seed / Aug 12, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Ippen Media invest in?
Ippen Media invests primarily in Retail, Consumer and Internet startups, most often at Seed and Venture - Series Unknown stage. Most of the 6 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Ippen Media's check size?
Ippen Media typically joins rounds of $7.8M–$11M at Seed and $10M–$47M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ippen Media participates in.
How do I contact Ippen Media?
Public channels for Ippen Media include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ippen Media?
The team at Ippen Media includes Benjamin Marx (CEO) and Jan Ippen (Founder and Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
